An AP-rated and therapeutically equivalent generic of Cardene IV (Chiesi) has been made available by American Regent.
Nicardipine HCl Injection, a calcium channel blocker, is indicated for the short-term treatment of hypertension when oral therapy is not feasible. The treatment is intended for intravenous use and is administered by slow continuous infusion following dilution.
The product is supplied in single-dose vials containing 25mg of nicardipine HCl in 10mL solution and is preservative free. According to the Company, it is available for immediate shipment.
“American Regent is pleased to be bringing back this shortage-prone product in a USP formulation, and to offer healthcare providers another option for the treatment of hypertension,” said Harsher Singh, Vice President, Chief Commercial and Strategic Officer at American Regent, Inc.
For prolonged control of blood pressure, patients should be switched to oral medication as soon as their clinical condition permits.
For more information visit americanregent.com.